Yıl: 2021 Cilt: 32 Sayı: 3 Sayfa Aralığı: 116 - 122 Metin Dili: İngilizce DOI: 10.4274/jtss.galenos.2021.99608 İndeks Tarihi: 21-10-2021

BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL

Öz:
Objective: Injury of the spinal cord is studied in two separate mechanisms as primary and secondary injuries. During the secondary injury,spinal cord damage and related neurological defects could increase mostly because of oxidative damage. Treatments targeting this process arepromising for reducing neuronal damage. Ganoderma lucidum (GL) has the potential to suppress the inflammatory response and oxidative stress.The aim of this study is to determine the neuroprotective effect of traditional GL hot-water extract during the secondary spinal cord injury (SCI)period on an experimental rat spinal trauma model by measuring the biochemical parameters.Materials and Methods: A total of 34 rats were distributed randomly into 4 groups as trauma, vehicle, low-dose medication group (low-DMG)and high-dose medication group (high-DMG). A modified Walsh-Tator clip was applied extradurally to form an experimental SCI model. GL liquidextract was performed in medication groups with low and high (10 times higher) oral doses. Spinal cord specimens were collected after 5 daysof treatment for biochemical analysis.Results: In the low-DMG, both diphenypicrylhydrasyl (DPPH) and malondialdehyde (MDA) values were found statistically negligible whencompared with the trauma group. Comparison of the Low-DMG and vehicle group showed a significant change in DPPH value, but an insignificantchange in MDA value. A statistically significant positive change in both DPPH and MDA values was found in High-DMG when compared to traumaand vehicle groups.Conclusion: Prevention of secondary SCI is very important, since the neurological condition of the patients may get worse during this period.Dose-dependent positive results were obtained in the favor of GL in terms of both antioxidant efficacy and prevention of lipid peroxidation afterSCI. The results of this biochemical study is supporting the previous studies and showing that GL has the potential of reducing posttraumaticoxidative damage in the spinal cord when given at the appropriate dose.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75:15-26.
  • 2. Fehlings MG, Sekhon LH, Tator C. The role and timing of decompression in acute spinal cord injury: what do we know? What should we do? Spine (Phila Pa 1976). 2001;26(Suppl 24):S101-110.
  • 3. Hardman J. Cerebrospinal Trauma. In: Davis R, Robertson D (Eds.). Textbook of Neuropathology. Second edition, Williams and Wilkins, Baltimore 1991;pp:962-1003.
  • 4. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997;3:73-6.
  • 5. İplikcioglu C. Omurilik yaralanmasının fizyopatolojisi. İçinde: Özer F, Zileli M (Eds.). Omurilik ve Omurga Cerrahisi. Birinci basım, Saray Medikal Yayıncılık, İzmir 2002;pp:459-65.
  • 6. Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci. 2008;9:481-93.
  • 7. Rossignol S, Schwab M, Schwartz M, Fehlings MG. Spinal cord injury: time to move? J Neurosci. 2007;27:11782-92.
  • 8. Tator C. Neurosurgery. In: Wilkins R, Rengachary S (Eds.). Second edition, McGraw-Hill, New York 1996;pp:2847-59.
  • 9. Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci. 2003;24:13-7. 10. Erden M. Serbest radikaller. Turkiye Klinikleri J Med Sci. 1992;12:201-7.
  • 11. Sakamoto A, Ohnishi ST, Ohnishi T, Ogawa R. Relationship between free radical production and lipid peroxidation during ischemiareperfusion injury in the rat brain. Brain Res. 1991;554:186-92.
  • 12. Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci. 1991;48:301-9.
  • 13. Chang ST, Buswell JA. Medicinal mushrooms-a prominent source of nutriceuticals for the 21st century. Curr Top Nutraceutical Res. 2003;1:257-80.
  • 14. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. In: Benzie IFF, WachtelGalor S (Eds.). Herbal Medicine: Biomolecular and Clinical Aspects. Second edition, CRC Press/Taylor & Francis, Boca Raton (FL) 2011.
  • 15. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, et al. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep. 2006;23:394-411.
  • 16. Lin Z-B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci. 2005;99:144-53.
  • 17. Sone Y, Okuda R, Wada N, Kishida E, Misaki A. Structures and antitumor activities of the polysaccharides ısolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agr Biol Chem. 1985;49:2641-53.
  • 18. Miyazaki T, Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull (Tokyo). 1981;29:3611-6.
  • 19. Soo TS. Effective dosage of the extract of Ganoderma lucidum in the treatment of various ailments. In: Royse DJ, (Ed.). shroom biology and mushroom products : proceedings of the 2nd International Conference, June 9-12, 1996, University Park, Pennsylvania. 1996;pp:177-85.
  • 20. Chang R. Effective dose of Ganoderma in humans. Taipei; 1994. p. 101-13. In: Buchanan P, Hseu R, Moncalvo J (Eds.). Proceedings of the Contributed Symposium 59A, B of the 5th International Mycological Congress. Taipei, 1994;pp:101-13.
  • 21. Cheung MC, Spalding PB, Gutierrez JC, Balkan W, Namias N, Koniaris LG, et al. Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res. 2009;153:326-31.
  • 22. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47:577-81.
  • 23. Li EK, Tam L-S, Wong CK, Li WC, Lam CWK, Wachtel-Galor S, et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: A doubleblind, randomized, placebo-controlled pilot trial. Arthritis Rethum. 2007;57:1143-50.
  • 24. Bondet V, Brand-Williams W, Berset C. Kinetics and Mechanisms of Antioxidant Activity using the DPPH free radical method. LWT Food Sci Technol. 1997;30:609-15.
  • 25. Kedare SB, Singh RP. Genesis and development of DPPH method of antioxidant assay. J Food Sci Technol. 2011;48:412-22.
  • 26. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl. 2000;742:315-25.
  • 27. Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol. 2001;24:265-79.
  • 28. Rivlin AS, Tator CH. Regional spinal cord blood flow in rats after severe cord trauma. J Neurosurg. 1978;49:844-53.
  • 29. Khan M, Griebel R. Acute spinal cord injury in the rat: comparison of three experimental techniques. Can J Neurol Sci. 1983;10:161-5. 30. Taoka Y, Okajima K. Spinal cord injury in the rat. Progress in Neurobiology. 1998;56:341-58.
  • 31. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int. 1995;11:151-66.
  • 32. Paterson RRM. Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 2006;67:1985-2001.
  • 33. Lindequist U, Niedermeyer THJ, Jülich W-D. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285-99.
  • 34. Hai-Bang T, Shimizu K. Structure–activity relationship and inhibition pattern of reishi-derived (Ganoderma lingzhi) triterpenoids against angiotensin-converting enzyme. Phytochem Lett. 2015;12:243-7. 35. Bensky D, Kaptchuk TJ. Chinese Herbal Medicine: Materia Medica. Eastland Press, Seattle, 1993;pp:556.
  • 36. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidants from ganoderma lucidum. Phytother Res. 1999;13:529-31.
  • 37. Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, et al. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLoS One. 2013;8:e57431.
  • 38. Palaoglu S. Akut Omurilik Yaralanmasının Tedavisinde İyileşmeyi Hızlandıran Farmakolojik ve Cerrahi Girişimler. Turk J Phys Med Rehabil. 2002;48. Available from: https://www.ftrdergisi.com/ abstract.php?id=3388 [Online ahead of print]
  • 39. Sun J, He H, Xie B. Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem. 2004;52:6646-52.
  • 40. Shi Y, James AE, Benzie IFF, Buswell JA. Mushroom-derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA. Teratog Carcinog Mutagen. 2002;22:103-11.
  • 41. Abdullah N, Ismail SM, Aminudin N, Shuib AS, Lau BF. Evaluation of selected culinary-medicinal mushrooms for Antioxidant and ACE ınhibitory activities. Evid Based Complement Alternat Med. 2012;2012:464238.
  • 42. Lin W-C, Lin W-L. Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World J Gastroenterol. 2006;12:265-70.
  • 43. Sudheesh NP, Ajith TA, Mathew J, Nima N, Janardhanan KK. Ganoderma lucidum protects liver mitochondrial oxidative stress and improves the activity of electron transport chain in carbon tetrachloride intoxicated rats. Hepatol Res 2012;42:181-91.
  • 44. You Y-H, Lin Z-B. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin. 2002;23:787-91.
  • 45. Zhou Y, Qu Z, Zeng Y, Lin Y, Li Y, Chung P, et al. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol. 2012;64:673-80.
  • 46. Zhou Z-Y, Tang Y-P, Xiang J, Wua P, Jin H-M, Wang Z, et al. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol. 2010;131:154-64.
  • 47. Gokce EC, Kahveci R, Atanur OM, Gürer B, Aksoy N, Gokce A, et al. Neuroprotective effects of Ganoderma lucidum polysaccharides against traumatic spinal cord injury in rats. Injury. 2015;46:2146-55.
  • 48. Kahveci R, Kahveci FO, Gokce EC, Gokce A, Kısa Ü, Sargon MF, et al. Effects of Ganoderma lucidum polysaccharides on different pathways involved in the development of spinal cord ıschemia reperfusion injury: biochemical, histopathologic, and ultrastructural analysis in a rat model. World Neurosurg. 2021;150:e287-97.
  • 49. Ekinci A, Ozevren H, Bilgiç BE, Ekinci C, Deveci S, Deveci E. Neuroprotective effects of Ganoderma lucidum on spinal cord injury. Int J Morphol. 2018;36:175-9.Yasir M, Goyal A, Bansal P, Sonthalia S. Corticosteroid Adverse Effects. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [cited 2021 Jul 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK531462/
  • 50. Noguchi M, Kakuma T, Tomiyasu K, Yamada A, Itoh K, Konishi F, et al. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms. Asian J Androl. 2008;10:777-85.
  • 51. Kim MJ, Kim HW, Lee YS, Shim MJ, Choi EC, Kim BK. Studies on Safety of Ganoderma lucidum. The Korean Journal of Mycology. 1986;14:49-59.
APA Divanlioglu D, SALİHOĞLU E, KORKMAZ M, SEÇEN A, öcal ö, GÜNERHAN G, Belen D, DALGIC A (2021). BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. , 116 - 122. 10.4274/jtss.galenos.2021.99608
Chicago Divanlioglu Denizhan,SALİHOĞLU Ece Miser,KORKMAZ MURAT,SEÇEN AHMET EREN,öcal özgür,GÜNERHAN GÖKSAL,Belen Deniz,DALGIC Ali BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. (2021): 116 - 122. 10.4274/jtss.galenos.2021.99608
MLA Divanlioglu Denizhan,SALİHOĞLU Ece Miser,KORKMAZ MURAT,SEÇEN AHMET EREN,öcal özgür,GÜNERHAN GÖKSAL,Belen Deniz,DALGIC Ali BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. , 2021, ss.116 - 122. 10.4274/jtss.galenos.2021.99608
AMA Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. . 2021; 116 - 122. 10.4274/jtss.galenos.2021.99608
Vancouver Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. . 2021; 116 - 122. 10.4274/jtss.galenos.2021.99608
IEEE Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A "BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL." , ss.116 - 122, 2021. 10.4274/jtss.galenos.2021.99608
ISNAD Divanlioglu, Denizhan vd. "BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL". (2021), 116-122. https://doi.org/10.4274/jtss.galenos.2021.99608
APA Divanlioglu D, SALİHOĞLU E, KORKMAZ M, SEÇEN A, öcal ö, GÜNERHAN G, Belen D, DALGIC A (2021). BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. Journal of Turkish Spinal Surgery, 32(3), 116 - 122. 10.4274/jtss.galenos.2021.99608
Chicago Divanlioglu Denizhan,SALİHOĞLU Ece Miser,KORKMAZ MURAT,SEÇEN AHMET EREN,öcal özgür,GÜNERHAN GÖKSAL,Belen Deniz,DALGIC Ali BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. Journal of Turkish Spinal Surgery 32, no.3 (2021): 116 - 122. 10.4274/jtss.galenos.2021.99608
MLA Divanlioglu Denizhan,SALİHOĞLU Ece Miser,KORKMAZ MURAT,SEÇEN AHMET EREN,öcal özgür,GÜNERHAN GÖKSAL,Belen Deniz,DALGIC Ali BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. Journal of Turkish Spinal Surgery, vol.32, no.3, 2021, ss.116 - 122. 10.4274/jtss.galenos.2021.99608
AMA Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. Journal of Turkish Spinal Surgery. 2021; 32(3): 116 - 122. 10.4274/jtss.galenos.2021.99608
Vancouver Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL. Journal of Turkish Spinal Surgery. 2021; 32(3): 116 - 122. 10.4274/jtss.galenos.2021.99608
IEEE Divanlioglu D,SALİHOĞLU E,KORKMAZ M,SEÇEN A,öcal ö,GÜNERHAN G,Belen D,DALGIC A "BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL." Journal of Turkish Spinal Surgery, 32, ss.116 - 122, 2021. 10.4274/jtss.galenos.2021.99608
ISNAD Divanlioglu, Denizhan vd. "BIOCHEMICAL ANALYSIS FOR NEUROPROTECTIVE EFFECTS OF GANODERMA LUCIDUM IN EXPERIMENTAL RAT SPINAL CORD TRAUMA MODEL". Journal of Turkish Spinal Surgery 32/3 (2021), 116-122. https://doi.org/10.4274/jtss.galenos.2021.99608